Neuronoff Secures $4.5 Million for Minimally Invasive Pain Treatment Platform

Neuronoff raises $4.5 million in financing to advance its Injectrode platform for minimally invasive pain treatments.

AI-assisted, human-published

Latest headlines

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here